Understanding the Anti-Kickback Statute, Safe Harbors, and Real-World Enforcement Risks

The Federal Anti-Kickback Statute (AKS) remains one of the most scrutinized and enforced healthcare fraud and abuse laws. With enforcement agencies ramping up investigations and recoveries under the False Claims Act (FCA) reaching historic highs, healthcare organizations face increasing compliance risks. This session will dissect the AKS, clarify what constitutes prohibited conduct, and explore available safe harbors that can protect legitimate business arrangements.

Attorney and healthcare compliance expert William Mack Copeland, MS, JD, PhD, LFACHE, will guide participants through key case law, OIG advisory opinions, and recent enforcement actions, providing actionable insights to help healthcare professionals safeguard against violations and minimize risk exposure.

Webinar Objectives

By the end of this session, participants will be able to:

• Understand the core provisions and intent of the Federal Anti-Kickback Statute and how it interacts with the False Claims Act.
• Identify safe harbor protections and apply them to real-world arrangements involving physicians, hospitals, and healthcare vendors.
• Analyze recent enforcement trends, settlements, and case law to understand the government’s evolving approach to AKS violations.
• Recognize how joint ventures, physician-owned entities, and management contracts can trigger AKS concerns and how to mitigate those risks.
• Develop compliance strategies and internal controls to avoid unintentional violations and protect their organization from costly penalties.

Webinar Agenda

I. Introduction and Legal Framework

• Background and intent of the AKS
• Overview of enforcement landscape and federal oversight

II. Understanding the Prohibited Conduct

• Defining “remuneration” and “referral”
• Common risk areas in healthcare arrangements

III. Safe Harbors Explained

• Review of regulatory exceptions
• Applying safe harbors to everyday business practices

IV. Case Law and Enforcement Insights

• Landmark and recent cases shaping AKS interpretation
• The AKS-FCA connection: when violations trigger False Claims liability

V. OIG Advisory Opinions and Guidance

• Joint Venture and Physician-Owned Entity opinions
• Implications for healthcare executives and compliance officers

VI. Compliance Takeaways and Q&A

• Key preventive measures and risk mitigation steps
• Interactive discussion and participant questions

Webinar Highlights

• The intersection of the Anti-Kickback Statute and the False Claims Act
• Review of key safe harbors—investment, space and equipment rental, personal services, and physician recruitment
• Insight into the OIG’s Joint Venture Advisory Opinion and its implications for hospitals and providers
• Discussion on physician-owned distributorships (PODs) and why OIG views them as “inherently suspect”
• Understanding the anti-fraud provisions of the Affordable Care Act and their connection to AKS compliance
• Practical lessons learned from recent enforcement cases and compliance best practices

Who Should Attend

• Hospital executives, particularly CEOs, COOs, CFOs, CNOs, and CMOs;
• Nursing home executives;
• Physicians;
• Physician practice managers; and
• Other healthcare provider executives.